14/11/2026
One patient. Type 2 diabetes, chronic kidney disease and heart failure.
For clinicians, the shared risk factors are only the starting point. The harder questions follow: How do you assess kidney risk beyond eGFR? How do you manage hyperkalaemia without giving up guideline-directed therapy? Where does obesity treatment fit once heart failure is present?
This World Diabetes Day, revisit the e-SPACE HF 2026 sessions on cardiorenal syndrome, HFpEF, and cardiometabolic-kidney disease, available on demand.
Watch on demand: https://www.espace-hf.org/2026/